Financial News
Headline News about Exelixis Inc
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_640-business-finance-and-saving-money-investment-money-coin-stack.webp)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3986.png?width=1200&height=800&fit=crop)
![](https://cdn.pixabay.com/photo/2015/01/15/16/17/hands-600497_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/cells-gdd37bc5d2_1920_16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1520.jpeg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3838.png?width=1200&height=800&fit=crop)
![](https://cms.zerohedge.com/s3/files/inline-images/ES%202022-02-18_7-24-37.jpg?itok=W6DtXQUc)
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1579.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_755.jpeg?width=1200&height=800&fit=crop)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_2403.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3509.png)
![](https://www.investors.com/wp-content/uploads/2021/03/Stock-DrugsPills-14-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/peek_into_the_marketnew_341.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://investorplace.com/wp-content/uploads/2020/10/cheap-stocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_396.jpg)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_annie-spratt-hwjsonawtqs-unsplash.jpg)
Uncertain Times
December 15, 2021
Via Talk Markets
![](https://g.foolcdn.com/editorial/images/649999/scientist-holding-test-tube.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3779.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_383.jpg)
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Via Benzinga
Topics
Retirement
Exposures
Pension
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Exelixis, inc (EXEL) Q3 2021 Earnings Call Transcript
November 02, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_498.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/roce_image_1240.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/virus-4030721_1920_10.jpg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech2_2.jpg)
![](https://g.foolcdn.com/editorial/images/648787/alzheimers.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/insider_trade_image_1368.jpeg)
Via Benzinga
Topics
Regulatory Compliance
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.